Blog
PCOS Is Now PMOS: What Actually Changed (and What Didn't)
Short answer: In May 2026, the global medical community adopted a new name for PCOS: polyendocrine metabolic ovarian syndrome, or PMOS. It's the result of a 14-year effort to fix a name that was never quite accurate. Your condition didn't change — its name did. Nothing about your day-to-day care changes today, and you'll keep seeing "PCOS" on your forms, chart, and prescriptions for years while the transition rolls out.
If you've searched "why was PCOS renamed" or "what is PMOS" and landed here confused, that's a completely reasonable reaction. Here's what actually happened.
What "polyendocrine metabolic ovarian syndrome" means, word by word
The new name is a mouthful on purpose — it's trying to describe more of the condition than the old one did.
- Polyendocrine — more than one hormone system is involved, not just the ovaries. PCOS touches insulin, androgens, and other hormone pathways at once.
- Metabolic — the name now names the metabolic side out loud: insulin resistance, blood sugar, and cardiovascular risk are part of the condition, not a side effect of it.
- Ovarian — the ovaries are still named, because they're still central to how the condition shows up (irregular ovulation, cycle changes).
- Syndrome — unchanged. It's still a collection of related features, not a single-cause disease with one test that confirms it.
Notice what's missing: "polycystic." That word is gone because it was the most misleading part of the old name.
Why the name changed
The change was published in The Lancet on 12 May 2026, in a paper titled "Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process."00717-8/fulltext) It wasn't a snap decision. It came out of a 14-year process led by Monash University, working with 56 academic, clinical, and patient organizations around the world, and drawing on surveys of more than 14,300 people with PCOS and clinicians across every world region.
The core problem the consensus process was trying to fix: "polycystic" is inaccurate. The ovaries involved in PCOS typically show numerous small follicles, not true cysts in the medical sense — so the name has been describing the wrong thing for decades. Beyond that one word, the old name anchored the entire condition in gynecology, which obscured its metabolic, cardiovascular, dermatological, and psychological dimensions. A name that only says "ovary" makes it easy for the rest of what PCOS actually involves — insulin resistance, heart disease risk, acne, hair changes, mood — to get lost or dismissed. That, in turn, has contributed to delayed diagnosis and to the stigma many people with PCOS already know well.
What changes for you today
Medically: nothing, yet. This is a naming update, not a new diagnostic standard or a new treatment protocol. The full implementation timeline runs through the 2028 International Guideline update — that's when the name change is expected to work its way into clinical guidelines worldwide in a formal way.
In practice, that means:
- Your insurance forms, medical records, and prescriptions will very likely keep saying "PCOS" for the foreseeable future. Coding systems and paperwork move slowly, and there's no expectation that they'll flip overnight.
- Your care doesn't need to change because of this. If you have a management plan with your clinician, this news isn't a reason to reopen it — unless something about your actual health has changed, which is a separate conversation to have with them.
- The two terms will coexist for a long stretch. Some clinicians will start saying PMOS sooner; many will keep saying PCOS out of habit, because it's what's in the record, or because it's what you already know. Neither one is "wrong" to use right now.
Why the community pushed for this
Renaming a condition that millions of people already know by its old name is a real cost, not a trivial one — and the people leading this process knew that. Part of why the change happened anyway is that the old name was doing active harm in two specific ways: it made PCOS sound like a narrow, cosmetic, ovary-only issue, which made it easier for the metabolic and cardiovascular risks to be overlooked in appointments; and the word "polycystic" itself has carried years of stigma, showing up in casual and even clinical conversations in ways that felt reductive to people living with the condition.
That's also why patient organizations were part of the 56 groups involved, and why more than 14,300 people with PCOS — not just clinicians — were surveyed as part of the process. This wasn't a name handed down from a committee in isolation from the people it describes.
If the rename still feels disorienting, that's fair. A name is part of how you've understood your own body, sometimes for years. It's worth repeating plainly: your condition didn't change. Its name did.
FAQ
Do I need a new diagnosis? No. If you were diagnosed with PCOS, that diagnosis stands. PMOS is a renaming of the same condition, not a new or different one, and there's no need to seek a fresh diagnostic workup because of the name change alone.
Will my doctor start saying PMOS? Gradually, and unevenly. Some clinicians will adopt the new term sooner, especially as it appears more in research and guidelines; others will keep using PCOS for a long time, partly because that's what's documented in your existing records. Expect both terms to show up in appointments for years.
Is "PCOS" still correct to use? Yes. It's the transitional and still-common term, and it's the one your records, prescriptions, and most current guidelines use today. Using it isn't outdated or wrong — it's simply the name in the middle of becoming the older one.
This article is educational and informational only. It isn't medical advice, diagnosis, or treatment, and it isn't a substitute for a conversation with a qualified healthcare provider — especially if a name change or a diagnosis has left you with questions about your own care.